Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 20 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 04 May 2016 Status changed from not yet recruiting to recruiting.